Body Mass Index and Prognosis of Patients With Stage II/III Gastric Cancer After Curative Gastrectomy: Completion of Perioperative Adjuvant Chemotherapy May Be a Confounding Factor

Overview of attention for article published in Frontiers in oncology, June 2022

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age and source (53rd percentile)

Mentioned by

twitter: 3 X users

Readers on

mendeley: 5 Mendeley

Summary X

So far, Altmetric has seen 3 X posts from 3 X users, with an upper bound of 7,791 followers.

New article: Body Mass Index and Prognosis of Patients With Stage II/III Gastric Cancer After Curative Gastrectomy: Completion of Perioperative Adjuvant Chemotherapy May Be a Confounding Factor https://t.co/2bLQ5WQ9la #pancreaticcancer #oncology https://t.

30 Jun 2022

Reply Repost Favourite

RT @FrontOncology: New research: Body Mass Index and Prognosis of Patients With Stage II/III Gastric Cancer After Curative Gastrectomy: Com…

13 Jun 2022

Reply Repost Favourite

New research: Body Mass Index and Prognosis of Patients With Stage II/III Gastric Cancer After Curative Gastrectomy: Completion of Perioperative Adjuvant Chemotherapy May Be a Confounding Factor: Objective To investigate the association… https://t.co/wHIf

13 Jun 2022

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.